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FOR in vivo study of the phenomena observed in vitro,
PMN (polymorphonuclear leukocyte) extravasation was
analysed quantitatively in the microcirculation of the
hamster cheek pouch using a video system. Topical
application of leukotriene B or N-formyl-methionyl-
leucyl-phenylalanine increased dose dependently the
number ofPMNs adhering to the venules. Eighty to 90%
of the adhering PMNs disappeared from the vascular
lumen into the venular wall within 10-12 rain after the
adhesion. After PMNs had passed through the endothelial
cell layer, they remained in the venular wall for more than
30 min after application of the chemoattractants and
appeared in the extravascular space. Thus, the process
could be divided into five steps: (1) rolling and (2)
adhesion to the endothelium, (3) passage through the
endothelial layer (4) remaining in the venular wall, and
(5) passage through the basement membrane.
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Introduction
Transmigration of polymorphonuclear leuko-
cytes (PMNs) from the circulation to the
extravascular space is one of the cardinal signs of
the acute inflammatory responses. At the micro-
circulatory level, PMNs have been described as
rolling along the venular wall1’2 and then adhering
to the inner surface of the endothelial cells. 1’3-s
Studies by electron micrography have also indicated
that PMNs penetrate the vessel wall between
endothelial cells.6- However, past observations,
made in vivo at the microcirculatory level, of the
process of transmigration of PMNs have been
mainly rather descriptive, and not quantitative.
The initial report from in vitro experiments that
incubation of interleukin-1 with cultured en-
dothelial cells from the human umbilical vein
increased their adhesivity for neutrophils
1 stimu-
lated studies on adhesion molecules. Since then,
many findings on adhesion molecules of neutrophils
and endothelial cells have been accumulated using
cultured endothelial cells and isolated neu-
trophils. 12’13 Two intercellular adhesion molecules,
ICAM-1 (intercellular adhesion molecules-I)
14 and
ICAM-2s have been identified on endothelial cells
in relation to neutrophil adhesion to these cells.
Simultaneously, studies of patients who show
repetitive infection and lack of PMN migration
16
have revealed congenital deficiencies of a family of
surface glycoproteins of leukocytes, which have
now been identified as adhesion molecules of the
integrin superfamily (CD11/CD18).
17
(C) 1992 Rapid Communications of Oxford Ltd
In spite of the extensive efforts made in
examining adhesion molecules in vitro, in order to
understand properly the phenomenon of neutrophil
extravasation, which occurs in vivo at the micro-
circulatory level, confirmation in vivo of the in vitro
findings is essential. Also, in order to discuss PMN
transmigration at the molecular level in vivo,
quantitative analyses are required.
We reported a quantitative analysis of the rolling
and adhesion ofPMNs induced by leukotriene (LT)
B4 and N-formyl-methionyl-leucyl-phenylalanine
(fMLP) in the microcirculation of the hamster cheek
pouch. The behaviour of PMNs in the vascular
lumen was quantified from changes in intensity of
images transmitted from a monochrome television
(TV) camera to a TV monitor screen, by using a
photocell placed on this screen, but the subsequent
steps ofPMN extravasation remain to be analysed.
The present experiments aim to give a
quantitative analysis of the entire process of the
transmigration of PMNs from the bloodstream to
the perivascular space at microcirculatory levels in
the cheek pouch of anaesthetized hamsters.
Materials and Methods
Preparation of hamster cheek pouch: The hamster cheek
pouch preparations were set up as previously
described. 3’s’18 Tracheal intubation ensured spon-
taneous respiration. The male golden hamsters
(Mesocricetus auratus, 120-150 g, 10-16 weeks old)
were anaesthetized with pentobarbital (Nembutal(R),
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Abbot Lab, Chicago, IL, USA) (60 mg/kg, i.p.).
The cheek pouch was everted, cut longitudinally,
and extended. The avascular connective tissue was
elaborately dissected away to expose the micro-
vasculature of the mucous layer. The thin mucous
membrane tissue was spread in a plastic chamber
(9 ml) and superfused at 5 ml/min with warmed
Tyrode’s solution, which was maintained at 37C.
Body temperature was maintained with a warming
pad positioned directly beneath the hamster and
maintained at 37C.
Microscopic observation and recording of leukocyte behaviour"
The microvasculature of the hamster cheek pouch
was observed with transillumination under a
microscope (BHA, Olympus Optical Co. Ltd,
Tokyo), using a water immersion lens ( 40) and
x 10 eyepieces (Olympus Optical Co. Ltd, Tokyo).
Images of the microcirculation were projected into
a TV monitor screen via a monochrone TV camera
(CTC 2600, Ikegami Tsushinki, Tokyo) mounted at
the top of a triocular microscope. The leukocyte
responses in each experiment were usually recorded
with a videotape recoder (VO-5850, Sony Co.,
Tokyo) and replayed after the experiments. The
rolling behaviour, adhesion to the vessel walls, and
migration to the extravascular space, of individual
leukocytes were clearly visible on the screen. The
observation and experimental procedures were
performed only once for each animal. The
behaviour of individual leukocytes in a post-
capillary venule of 13-15 #m diameter were
observed over a 110/m length along a venule.
During the 30 min equilibration period, margina-
tlng leukocytes could be visualized inside the
venules as they rolled along the endothelium at a
lower velocity than the bulk flow.
Chemotactic agents: LTB4 (Paesel, Gmbh and Co,
Frankfurt) and fMLP (Peptide Institute, Minoh,
Osaka) were used as chemoattractants. Stock
solutions of LTB4 (30/M in absolute ethanol) or
fMLP (1 mM in saline) were kept frozen at --70C
and diluted to appropriate concentrations with
Tyrode’s solution immediately before use.
Application of LTB4 and fMLP: The superfusion of
the cheek pouch with Tyrode’s solution was
stopped during the experiments. LTB4 or fMLP
solution was applied to the microvasculature at the
observation sites with a 50/1 micropipette.
Electron microscopy: Before and 30 min after the
application of LTB4, parts of the thin preparation
of the hamster cheek pouch used for examination
of the microcirculation were fixed in 2.5%
glutaraldehyde and 1% osmium tetroxide. Ultra-
thin sections were cut on a LKB ultramicrotome
and were stained with uranyl acetate and lead
citrate, and observed by a JEM-1200EX electron
microscope (JEOL Ltd, Tokyo).
Results
Rolling: In the absence of chemoattractants, a few
PMNs could be individually visualized as bright
white ceils against the dark background of the
blood stream, since they rolled slowly on the
endothelial wall. Although the number of rolling
PMNs was quite variable from preparation
to preparation, the majority of the rolling
PMNs moved in a jerky fashion, then came to rest
suddenly for short, but variable periods of time
(3--30 s), and finally returned to the bloodstream
(Fig. 1). The behaviour of a PMN moving slowly
along the endothelial surface and stopping at the
same site for less than one minute was designated
as ’rolling’. Some PMNs rested at the same site for
longer periods, but eventually they moved again
(Fig. 2).
On the application of a chemoattractant (either
LTB4 or fMLP) the number of rolling PMNs was
kept constantly low and was not increased (Fig. 2),
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FIG. 1. Times for which PMNs remained at the same site in a venule after
topical application of LTB4 and fM LP. The abscissa indicates the ranges
of time spent by the same PMNs at the same site on the inner surface of
the venules. The ordinate indicates the cumulative numbers of PMNs
remaining for each time range, counted in a 110 Fm length along a venule
on the monitor screen for 50 min after the application of LTB4 or fMLP.
Values indicate the mean (_+ SE) from five to six animals.
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FIG. 2. Changes in the numbers of rolling PMNs after LTB4 and fMLP
application. The abscissa indicates the time lapse after the application of
LTB4 or fMLP (arrowhead, 0). The ordinate indicates the numbers of
PMNs counted in a 110 #m length along a venule on the monitor screen,
recorded for 50 min after application of LTB4 or fMLP. Values indicate
the means (+SE) obtained from the respective number of animals (n).
whereas the number ofPMNs remaining for longer
than one minute at the same site was markedly
increased dose dependently (Fig. 1). The behaviour
of a PMN remaining at the same site for one minute
or longer, was designated as ’adhesion’.
Adhesion" Figure 3 indicates the changes in the
number of adhering PMNs in a 5 min period upon
topical application of a chemoattractant. In absence
of chemoattractants, the number of adhering PMNs
was constantly low. Immediately after the applica-
tion of LTB4 or fMLP, adhesion was clearly
induced. The number of adhering PMNs was
increased dose dependently by the application of
either LTB4 or fMLP, and then the effect slowly
waned. The cumulative numbers of adhering PMNs
over a period of 50 min after the application of 0.15,
1.5, and 15 pmol/50/l of LTB4 were 7.8 4-3.1
(n=5), 21.0 4- 3.9 (n=6), 31.8-F6.4 (n--6)
(mean 4- SE), respectively and those after 1, 3 and
10 nmol/50 #1 of fMLP were 13.3 4- 6.2 (n 5),
25.7 4-3.5 (n= 5) and 45.04-6.0 (n--5), re-
spectively.
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FIG. 3. Changes in the numbers of adhering PMNs after LTB4 and fMLP.
The abscissa indicates the time lapse after LTB4 or fMLP application
(arrowhead, 0). The ordinate indicates the numbers of PMNs newly
adhering to a 110/m length along a venule on the monitor screen,
recorded for 50 min after LTB4 or fM LP application. Values indicate the
means (-t-SE) obtained from the respective numbers of animals (n).
Passage through the endothelial cell layer: Observation of
PMNs on the videotapes revealed that those PMNs
that were adhering to the venular wall had a large
area of contact with it (Fig. 4B). This contact area
was then seen to diminish as the cells became
thinner and ’taller’ (Fig. 4C), and then to decrease
their ’height’ gradually (Fig. 4D and E), until they
finally disappearedfrom the vascular lumen. The
A C
5 #m
FIG. 4. Schematic illustration of the shape of one PMN that was rolling
and then adhered to the surface of a venule and disappeared from the
vascular lumen after the application of LTB4. This illustration was
reconstructed from a series of frames on the videotape after the
application of LTB4 (15 pmol/50/l). (A) Rolling PMN, 3s before
adhesion. (B) The onset of adhesion, 0 sec. (C) min and 10 s after
adhesion. (D) 4 min and 40 s after adhesion. (E) 5 min and 10 after
adhesion.
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Table 1. Time from adhesion of PMNs to disappearance from the vascular lumen after
the application of LTB4 and fMLP
Treatment Numbers of Numbers of Time to disappearance
animals used PMNs observed mean _+ SE (min)
LTB4 (pmol/50/1)
0.15 5 10 9.5 + 1.9
1.5 6 30 11.4 _+ 1.1
15 6 30 10.0 + 0.9
fMLP (nmol/50/1)
5 10 9.2 + 2.1
3 5 20 10.2 + 1.0
10 5 25 12.0 _+ 1.3
average time from the onset of adhesion to
disappearance from the vascular lumen was about
10 min, irrespective of the dose of LTB4 or fMLP
(Table 1). The shortest time recorded was 3 min
and the longest was 25 min.
Figure 5 indicates that 80-90% of the PMNs,
which had adhered to the venular wall, disappeared
into it irrespective of the dosage of LTB4 (1.5 to
15 pmol/50 1) or fMLP (1 to 10 nmol/50 1), and
never returned to the bloodstream.
Presence in venular wall: Subsequent to passage through
the endothelial cell layer, PMNs remained for
longer than 30 min in the venular wall between the
endothelial cell layer and the basement membrane
of the pericytes/endothelial cells, as shown in the
electron micrograph in Fig. 6. Parts of the vascular
wall were seen on the TV monitor screen to become
thicker, possibly as a result of the PMNs present in
the wall.
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Migration into extravascular spaces: The number of
PMNs in the extravascular space, observed up to
90 min after the application of LTB4 or fMLP,
increased with time (Fig. 7). When observed on the
monitor screen during its migration into an
extravascular space, a PMN would extend the
process through an exit in the vascular wall into
the extravascular space, and this was followed by
amoeboid movement of the whole cell into the
interstitial space.
The time taken for a PMN to enter the
extravascular space completely ranged from 11 to
49 min, with a mean time of 25 to 34 min (Table 2).
Histological examination of the hamster cheek
pouch revealed that the migrating cells were almost
exclusively of the PMN type or neutrophils.
Discussion
The photocell method of quantitative analysis of
PMN behaviour, described in the previous paper,
is useful for when PMNs are rolling and adhering
to the inner wall of the venules. However, the
method is of no use after penetration of the
endothelial cell layers by the PMNs. In the present
experiments, the number of PMNs was counted
FIG. 5. Number of PMNs that disappeared from the vascular lumen as
percentages of those of PMNs that adhered after LTB4 and fMLP were
applied. The abscissa indicates the concentrations of LTB4 or fMLP. The
ordinate indicates the numbers of PMNs that disappeared from the FIG. 6. An electron micrograph of a postcapillary venule from the hamster
vascular lumen expressed as percentages of PMNs that adhered, as cheek pouch during PMN extravasation. A PMN remains between the
recorded for 50 min after the application of LTB4 or fM LP. Values indicate endothelial layer and the basement membrane of the venular wall for
the means (___SE) from the numbers of animals indicated at the top of 30 min after application of LTB4 (15 pmol/50 #1). A scale at the left
the respective columns, bottom indicates /m. x 6500.
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FIG. 7. Cumulative numbers of PMNs appearing in the extravascular space after LTB4 or fMLP application. The abscissa indicates the time
lapse after the application of LTB or fMLP. The ordinate indicates the total numbers of PMNs in the perivascular space at given times after the
application of LTB4 (15 pmol/50.#l) or fMLP (10 nmol/50 #1). Values indicate the means (-I-SE) from five to six animals.
with the naked eye directly on the TV monitor
screen during repeated replays of videotapes. This
was not an elegant technique, but adequate for
quantifying the behaviour of PMNs during
extravasation.
In the absence of chemoattractants, only a few
PMNs were visible rolling or remaining on the
inner wall of the venules. The period of time for
remaining at the inner wall was 3-30 s, and then
the PMNs returned to the bloodstream. Topical
application of LTB4 or fMLP on the surface of the
microvasculature did not change the number of
roiling PMNs, but resulted in an increase in the
number that remained adhering at the same site for
at least 60 s (Fig. 1). Thus, the designation of
rolling, in which PMNs were stationary for less
than 1 min at one site, and that of adhesion, in
which they remained at the same site for 1 min or
longer, are reasonable. A small number of rolling
PMNs were present in the venules before the
application of chemoattractants, but this may be
attributable to the manipulation of the cheek pouch
during the extensive dissection during setting up
the preparation and this manipulation may have
caused the release of endogenous agents. The
rolling behaviour of PMNs may be related to
activation of the selectin family.
19
The topical application of a chemoattractant
Table 2. Time from disappearance of PMNs from the vascular lumen to appearance
in the perivascular space after LTB4 and fMLP application
Treatment Numbers of Numbers of Time to disappearance
animals used PMNs observed mean _+ S.E. (min)
LTB4 (pmol/50/1)
0.15 5 10 32.4 _+ 3.0
1.5 6 30 25.3 _+ 1.4
15 6 30 3116 ___
1.9
fMLP (nmol/50/1)
5 10 29.8 +_ 2.7
3 5 20 34.0 +_ 2.0
10 5 25 31.8 _+ 1.9
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(LTB4 or fMLP) increased the cumulative numbers
of adherent PMNs, in accordance with the
concentration used (Fig. 3). This result confirms
those of the previous paper. As the adhering and
migrating cells were almost exclusively of the PMN
type or neutrophils, as shown by histological
examination, it can be concluded that LTB4 or
fMLP induced extravasation of neutrophils.
After in vitro experiments, the potency of LTB4
was reported to be equipotent to that of C5 in
chemotaxis,
2 to that of C5des-Arg or fMLP in
chemokinesis and chemotaxis,
21 and weaker than
fMLP in release of the lysosomal enzymes from
human PMN in the presence of cytochalacin B.
22-25
In the present in vivo experiments, the concentration
of fMLP for induction of PMN adhesion was 1000
times higher than those of LTB4. This is in
agreement with the previous report. The reasons
for the discrepancy between in vitro and in vivo
experiments are not known, but hamster PMNs
may be less sensitive to fMLP, and, as has already
been reported, the effect of fMLP on adhesion of
PMNs to the inner wall of venules is indirect in the
hamster, since it is completely inhibited by a
5-1ipoxygenase inhibitor. Despite the difference in
potency, LTB4 and fMLP share similar effects on
the process of the extravasation of PMNs in the
microcirculation of the hamster cheek pouch.
Adhesion of PMNs was observed only in the
venules. The increased adhesion of leukocytes is
primarily due to elevated adhesive forces and not
the result of decrease in dispersive forces, e.g., wall
shear stress.
26 Induction of PMN adhesion to the
venular endothelium was attributable to changes in
the membrane of the PMNs and not to that of the
endothelial cells, as was indicated in the previous
paper, in which selective application of a minute
amount of LTB4 with a glass capillary pipette close
to the capillary wall induced adhesion in the venules
downstream, whereas injection close to the venular
wall did not cause the adhesion of PMNs to it, but
induced adhesion in the larger venules further
downstream. High-affinity receptors for fMLP are
reported to be present on the surfaces of
leukocytes
27 and of cultured endothelial cells.
28
Thus, as indicated by in vitro experiments. Mac-1
(CD11b/CD18) and/or LAF-1 (CD11a/CD18) may
be adhesion molecules of neutrophils, which are
activated by LTB4 or fMLP and bound to the
counter-receptor ICAM-1 on the surface of
endothelial cells. 12 In our preliminary experiments
in vivo, this adhesion in the hamster check pouch
was blocked by an antibody against rat CD18 or
ICAM-1 (data to be published).
The present quantitative study revealed that
almost all (80-90%) of the PMNs that had adhered
to the venular walls, disappeared from the vascular
lumen through the endothelial cell layer and did not
return to the bloodstream. Thus, the adhesion of
PMNs to the endothelial cells is the pivotal step in
the process of PMN extravasation.
The disappearance of a PMN from the vascular
lumen into the venular wall took about 10 min. This
movement of PMNs must require detachment or
inactivation of Mac-1 and LFA-1 with crosstalk to
other adhesion molecules. The disappearance of
PMNs from the vascular lumen probably takes
place by passage through the endothelial cell
junctions, as indicated by electron micrographs.
6-1
PMNs that had passed through the endothelial
cell layer did not immediately appear in the
perivascular space, but remained in the spaces
between the endothelial cells and the basement
membrane of the pericytes/endothelial cells. This
observation confirmed the findings of previous
reports.6’1’29 An important finding of the present
study was that nearly 30 min elapsed before the
appearance of PMNs in the extravascular space
from disappearance from the vascular lumen (Table
2). PMNs may split the basement membrane
with collagenase/gelatinase, since the last step was
inhibited by a selective inhibitor of metallo-
proteinases (data published separately). Thus,
30min may be the time required for PMNs to
prepare metalloproteinases for action. Furthermore,
this last step of the passage of PMNs through the
basement membrane was inhibited by pretreatment
of the animals with dexamethasone.3’3
The results presented above indicate that PMN
extravasation by chemoattractants is not a simple
phenomenon, but a serial process in which a variety
of adhesion molecules on the surface of PMNs,
endothelial cells and other components of the
venular wall may be involved. The process can be
divided into five steps: (1) rolling on the
endothelium, (2) adhesion to the endothelium, (3)
passage through the endothelial layer, (4) presence
between the endothelial cells and the basement
membrane within the venular wall, and (5) passage
through the basement membrane into the extra-
vascular space. Quantitative analysis of the
extravasation of PMNs is necessary to clarify
precisely the underlying mechanism, particularly at
the molecular level. Individual steps may be
targeted for development of new drugs, which
inhibit PMN migration.
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